Clinical Trial Update: Brentuximab Vedotin or B-CAP in the Treatment of Older Patients With Newly Diagnosed Classical Hodgkin Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating Brentuximab Vedotin versus the B-CAP regimen in older patients with newly diagnosed classical Hodgkin lymphoma. The stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Drugs mentioned

• B-CAP
• Brentuximab vedotin (Brentuximab vedotin)

Snippet

Sponsor: University of Cologne | Conditions: Hodgkin Lymphoma | Phase 2 | Status: COMPLETED